本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Compugen醫療

2.87
+0.280010.81%
盤後2.900.0300+1.05%19:58 EDT
成交量:79.98萬
成交額:225.42萬
市值:2.71億
市盈率:7.69
高:2.91
開:2.60
低:2.59
收:2.59
52周最高:3.24
52周最低:1.30
股本:9,455.41萬
流通股本:9,245.75萬
量比:2.03
換手率:0.87%
股息:- -
股息率:- -
每股收益(TTM):0.3733
每股收益(LYR):0.3783
淨資產收益率:50.64%
總資產收益率:15.46%
市淨率:3.06
市盈率(LYR):7.59

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/10

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/05

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/30

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/05/06

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]